MCM2 and neoplasm: As compared with CDCP1– cells from muKras tumor cells (DKs5 and HK2-10), the matched CDCP1+ fraction expressed lower levels of markers for cell proliferation, including Ki67, PCNA, and MCM2 (Fig 2G).